MHE Staff

Content of this article was sponsored by Arbor Pharmaceuticals, LLC. Copyright 2020. This Managed Healthcare Executive® publication provides key information regarding a review by Faraone, et al, which was originally published in the Journal of the American Academy of Child & Adolescent Psychiatry (doi: 10.1016/j.jaac.2019.06.012). The authors of the original review are Stephen V. Faraone, PhD; Anthony L. Rostain, MD; C. Brendan Montano, MD; Oren Mason, MD; Kevin M. Antshel, PhD; Jeffrey H. Newcorn, MD. Please consult the full published review for complete information.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Third of three parts. See more in our Surveys tab.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. Second of three parts. See more in our Surveys tab.

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. First of three parts. See more in our Surveys tab.

Biosimilar misinformation takes many forms, some of it institutionalized in the form of word usage and some of it deliberately disparaging, 2 executives of Sandoz and Boehringer Ingelheim contend.

An experimental coronavirus vaccine called AZD1222 triggered an immune response against COVID-19 in study participants, and it has only minor side effects.

When universal testing was implemented, 40% of the tested residents were positive for SARS-CoV-2.

The Network’s Board of Trustees has appointed Mansue as the new president and CEO, effective September 1. She will succeed John DiAngelo, who announced his intention to retire in January following his 20-year tenure with the organization.

The higher case-fatality rate could be because of low resting rates, a greater number of deaths, or both,

Drug development in key areas of unmet need hit milestones this week, with Biogen, AstraZeneca, and Jaguar Health announcing regulatory steps with the FDA.

Federal agency is dispatching Quality Improvement Organizations to hotspots.

The new plan, called Gravie Comfort, offers 100% coverage on most common healthcare services, including preventive care, primary care, specialist visits, labs and imaging, generic prescriptions, online care, and more – all at a cost comparable to most traditional group health plans.

Lowering the age and smoking history standards would result in substantially more Blacks and women being eligible for screening.

Almost 40% of trials are designed to have fewer than 100 patients.

Spotlight report on healthcare discredits the widely held belief that external threats would lead to an increase in data breaches during the COVID-19 pandemic.

Strategic partnership combines software-as-a-service platform with locum tenens staffing to empower healthcare organizations of all sizes to measure, pinpoint and address clinician burnout.

A new handbook for facility managers and building owners offers in-depth guidance for how to ensure HVAC systems are properly maintained and upgraded to minimize virus spread.

A new report from the U.C. Berkeley Labor Center and Working Partnerships USA released today shows how technology is likely to impact job quality in healthcare and suggests that technological adoption may accelerate as a result of the COVID-19 pandemic.

Will produce recommendations for policymakers on crucial issues for future of remote care services.

How will they match up against ezeimbe, Repatha and Praluent?

Filling a void left by the Trump Administration, the Association for Community Affiliated Plans (ACAP) recently announced a campaign to remind Americans who need health insurance because of the COVID-19 that they may be eligible for coverage through healthcare.gov.

Drug makers around the world are racing to develop the first effective COVID-19 vaccine. Early efforts show promise, but an anticipated jump in the novel coronavirus cases in the fall means the sooner a vaccine is developed, the more lives can be saved-and the pharmaceutical industry plays a major role in this discovery.

COVID-19 is "laying bare the lethal inequality" of American society and health care, says Adam Gaffney, M.D., the lead author of a study about COVID-19 risk and insurance coverage.

Cancer researchers at Children's Hospital of Philadelphia (CHOP) are repurposing tools used for the development of cancer immunotherapies to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the same approach used to elicit an immune response against cancer cells to stimulate an immune response against the virus.

Nothing can bring a healthcare system to its knees quite like a pandemic. What COVID-19 is leaving in its wake is a new respect for numbers - for accurate data that can predict new threats, track current ones and trigger an avalanche of innovative responses.

As COVID-19 has spread around the world, data has shown that those with weakened immune systems are among the most susceptible to severe illness from the virus.

Anesthesia practices see major financial hit as physician anesthesiologists pivot during COVID-19 to treat patients in critical care and ICUs, ASA survey highlights.